CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Albany Molecular Research Incorporated Company Snapshot
Albany Molecular Research Incorporated operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Albany Molecular Research Incorporated with three other companies in this sector in the United States: Luminex Corporation (2016 sales of $270.64 million ), Genmab A/S ($269.31 million of which 100% was Pharmaceticals), and Medpace Holdings Inc ($370.62 million ).

Sales Analysis. Albany Molecular Research Incorporated reported sales of $570.45 million for the year ending December of 2016. This represents an increase of 41.8% versus 2015, when the company's sales were $402.36 million. Sales at Albany Molecular Research Incorporated have increased during each of the previous five years (and since 2011, sales have increased a total of 175%). Sales of Api saw an increase of 60.1% in 2016, from $216.95 million to $347.23 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Albany Molecular Research Incorporated
  Stock Performance Chart for Albany Molecular Research Incorporated
 
  Stock Data: Recent Stock Performance:
  Current Price (6/23/2017): 21.71
(Figures in U.S. Dollars)
1 Week 0.3%   13 Weeks 15.4%  
4 Weeks 64.3%   52 Weeks 60.7%  
 
Albany Molecular Research Incorporated Key Data:
  Ticker: AMRI Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 570,450,000
(Year Ending Jan 2017).
Employees: 3,085
  Currency: U.S. Dollars Market Cap: 932,048,770
  Fiscal Yr Ends: December Shares Outstanding: 42,931,772
  Share Type: Common Closely Held Shares: 12,582,366
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.